Showing results (1-10 of 1,009) with videos related to
Sort By:
Pageof 101
The Journal of Organic Chemistry|October 25, 2001
P(RNCH(2)CH(2))(3)N: Efficient Catalysts for Transesterifications, Acylations, and DeacylationsPalanichamy Ilankumaran, J. G. VerkadeThe Lancet. Oncology|August 21, 2020
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trialVivek Subbiah, Ulrik Lassen, Elena Élez, et al.Blood|September 15, 2022
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemiaRobert J Kreitman, Philippe Moreau, Farhad Ravandi, et al.Current Problems in Cancer|October 28, 2021
Optimizing anti-body drug conjugates and radiopharmaceuticals for precision therapy: The next frontier in precision oncologyVivek SubbiahMed (New York, N.Y.)|March 14, 2026
Matching hallmarks of cancer complexity with N-of-1 precision oncologyVivek SubbiahCancer Discovery|October 17, 2025
Rethinking Cancer Drug Development through Tumor-agnostic Precision MedicineVivek SubbiahJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 12, 2011
How watching the movie Zombieland helps treatment of cancer in teenagersVivek SubbiahSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 13, 2010
Adolescent oncology: who cares?-the new KID on the blockVivek SubbiahCurrent Oncology Reports|July 18, 2014
Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderlyVivek SubbiahPageof 101